In the rapidly evolving bio/pharmaceutical industry, integrating advanced technologies and patient-centric strategies is crucial for formulation success. This article by Pharma Tech explores how digitalization, artificial intelligence (AI), and machine learning (ML) are revolutionizing drug development.
By leveraging these technologies, companies can enhance efficiency, predict outcomes, and minimize formulation failures, ultimately leading to more effective and patient-friendly therapies.
Dr. Asma Patel, vice president of Integrated Development Services at Quotient Sciences, points out that patient centricity is a growing need for pediatric patients as these patients require age-appropriate and palatable dosage forms.
Continue reading the article on Pharma Tech.